CJC NO DAC/Ipamorelin Blend

This blend combines CJC-1295 without DAC (also known as Modified GRF 1-29) with Ipamorelin. CJC-1295 acts as a GHRH analog while Ipamorelin is a selective ghrelin mimetic. Together they synergistically stimulate growth hormone release through complementary receptor pathways, making this a popular combination in GH research. It is classified under the Growth Peptides research category and is studied in the following areas: Growth Hormone, GHRH Pathway, Muscle Growth, Recovery.

Our CJC NO DAC/Ipamorelin Blend is tested at 99%+ purity via third-party HPLC analysis. Every order ships with a Certificate of Analysis (COA) documenting purity, identity, and endotoxin levels.

CJC NO DAC/Ipamorelin Blend should be stored at -20°C. It is supplied as a lyophilized powder and is soluble in bacteriostatic water.

Dual mechanism: CJC-1295 (Modified GRF 1-29) acts as GHRH analog at pituitary GHRH receptors; Ipamorelin acts as selective ghrelin mimetic at GHSR-1a. Synergistic GH release.

CJC NO DAC/Ipamorelin Blend has a molecular weight of Blend. Its amino acid sequence is: CJC-1295 no DAC + Ipamorelin Blend.

Yes. Every batch of CJC NO DAC/Ipamorelin Blend is third-party tested and ships with a full Certificate of Analysis (COA) documenting HPLC purity, mass spectrometry identity confirmation, and endotoxin testing results.

CJC-1295 no DAC: ~30 minutes; Ipamorelin: ~2 hours

In published research, CJC NO DAC/Ipamorelin Blend has been administered via subcutaneous injection. All use is for laboratory research purposes only.